Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Xiamen Amoytop Biotech Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Xiamen Amoytop Biotech has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥390.8M respectively. Xiamen Amoytop Biotech's EBIT is CN¥770.8M making its interest coverage ratio -94.7. It has cash and short-term investments of CN¥424.8M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -94.7x |
| Nakit | CN¥424.77m |
| Eşitlik | CN¥2.01b |
| Toplam yükümlülükler | CN¥390.79m |
| Toplam varlıklar | CN¥2.40b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors
Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%
Sep 19Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?
Jun 12Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 04Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk
Mar 25Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 688278's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥315.0M).
Uzun Vadeli Yükümlülükler: 688278's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥75.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 688278 is debt free.
Borcun Azaltılması: 688278 has no debt compared to 5 years ago when its debt to equity ratio was 11.2%.
Borç Kapsamı: 688278 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 688278 has no debt, therefore coverage of interest payments is not a concern.